Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited released an announcement on 30 May 2026 detailing the latest composition of its Board of Directors and the membership of its four specialized committees.

The Board now consists of 11 members: six executive directors, one non-executive director, and four independent non-executive directors. Executive Director Mr. Chen Jiehui has been confirmed as Chairperson, with Mr. Yuan Cheng serving as Vice Chairperson. Independent oversight is provided by Mr. Wong Lung Tak Patrick, Ms. Sun Baoqing, Mr. Wu Xiangneng, and Mr. Yang Yinbao.

Committee assignments are as follows:

• Audit Committee: Chaired by Mr. Wong Lung Tak Patrick, with Ms. Sun Baoqing, Mr. Wu Xiangneng, and Mr. Yang Yinbao as members. • Strategic Development & Investment Committee: Chaired by Mr. Chen Jiehui; members include Mr. Yuan Cheng, Mr. Cheng Hongjin, Mr. Tang Heping, Ms. Liu Lan, Mr. Liu Hong, Mr. Huang Jiyuan, Ms. Sun Baoqing, Mr. Wu Xiangneng, and Mr. Yang Yinbao. • Nomination & Remuneration Committee: Chaired by Mr. Yang Yinbao, with Mr. Wong Lung Tak Patrick, Ms. Sun Baoqing, and Mr. Wu Xiangneng as members. • Budget Committee: Chaired by Mr. Wu Xiangneng; members include Mr. Chen Jiehui, Mr. Yuan Cheng, Mr. Cheng Hongjin, Mr. Tang Heping, Ms. Liu Lan, Mr. Liu Hong, Mr. Huang Jiyuan, and Mr. Yang Yinbao.

The diversified committee leadership underscores the company’s governance focus, assigning independent directors to key oversight roles in audit, nomination, remuneration, and budgeting. The updated structure is effective immediately, reflecting Guangzhou Baiyunshan Pharmaceutical’s ongoing efforts to strengthen corporate governance and strategic decision-making.